Factsmachine
Posted - 53 minutes from now
$BLRX adding more here.. pay-tience. You all lack it . We were at .70 pre market … over reaction.
xoxoxoxo1
Posted - 38 minutes from now
$BLRX let’s get to .10 cents. Why not?! FDA approval and a penny stock. Totally makes sense
Bakhmutbull2
Posted - 23 minutes from now
$BLRX Those long short funds and hedge funds own it through and through. I took my marbles and 12k loss and bought some more bitcoin. Good luck
gargoyl
Posted - 6 seconds from now
$BLRX HPS was originally formed as a division of Highbridge Capital Management within J.P. Morgan Asset Management and known as Highbridge Principal Strategies. Morgan Stanley (JPM grandson owns 197,000 shares of BLRX)
Black Rock (who bought out Kreos Capital )is buying out Highbridge , which already bought out Gamida whose parent company is Ayrmid LTD who just scooped up rights to APHEXDA .. can’t make this stuff up. …. Ask chatGBT
PHILMYWALLET
Posted - 10 minutes ago
$BLRX don't listen to pumpers on here. It's the same ones that have been on here for years trying to convince gullible folks to buy this Israeli trash. Don't listen to them
Lstreak
Posted - 22 minutes ago
$BLRX Well CEO and crew managed to raise money to have their salaries paid for for the next few years and screw shareholders again.
BLRXlongRIPorYOLO
Posted - 24 minutes ago
$BLRX wow my short yesterday really paid off. Thanks Phil you're the best.
Kensei
Posted - 25 minutes ago
$BLRX im holding my part. I will not sell at this point.
JJToni
Posted - 25 minutes ago
$BLRX company has now 50M+ in hands and revenue coming from 2 fronts: Gloria & Gamida with big focus now on PDAC & rest of pipeline. BTW PDAC expected completion date is mid 2025..
JrNannies
Posted - 33 minutes ago
$BLRX if sell let it burn that's what they want. No appreciation for shareholders
DiaJay
Posted - 34 minutes ago
$BLRX I don’t see how it recovers?
JrNannies
Posted - 41 minutes ago
$BLRX please everyone sell
Limey42
Posted - 59 minutes ago
$BLRX ouch. Going to take some monumental news to turn this ship around!
HitstheGreen
Posted - 1 hour ago
$BLRX
Humperdink
Posted - 1 hour ago
$BLRX
Harold_the_Hedge
Posted - 1 hour ago
$BLRX and highbridge involved again, same as $gmdaq. Sell and stay away, there is nothing left of interest here. Just my humble advice. Walk away proud
Humperdink
Posted - 1 hour ago
$BLRX
LockMan
Posted - 1 hour ago
$BLRX I think this is a drastic over-reaction. I blocked the dumb negative posters. Just adds a distraction to the overall picture. I said earlier, I am disappointed in this company as I have been a shareholder from the beginning, and it has been my biggest investment. Sure I hoped to make money. But I also had/have hopes for all those that NEED the product, which is why I originally invested. I am not giving up hope. Just wait for what happens.
swarty
Posted - 1 hour ago
$BLRX I still believe this drug will change the world. MM was always a step with PDAC being the prize. They had an ambitious plan to fund the PDAC through aggressive sales and it didn't work. It's never easy to admit a mistake and move on but they have and now the realignment is happening. I sold a large chunk of my holdings earlier this year when it became evident the plan wasn't going to work. But I held a small chunk to ride through this and I will buy back in to a large position eventually. None of this is easy - second guessing is noise - what are you doing to achieve the end game. They are taking the steps needed and as many great companies do - they will learn from their mistakes. This drug will change the world of cancer treatment. I won't go bear or bull on this - just hopeful. In the end, we WANT this company to succeed. Anyone who has lost a loved one to glioblastoma, ovarian, prostate, or pancreatic cancer understands.
LockMan
Posted - 1 hour ago
$BLRX The agreement enables significant reduction in BioLineRx's operational expenses and debt, and allows the company to focus on development activities in areas of high unmet need in oncology and rare diseases. Additionally, BioLineRx retains rights to develop and commercialize motixafortide in solid tumors, including PDAC
LockMan
Posted - 1 hour ago
$BLRX They will still be makin royalties, but with no expense. Plus the upfront money: BioLineRx granted Ayrmid an exclusive license to develop and commercialize APHEXDA (motixafortide) across all indications, excluding solid tumor indications, and in all territories other than Asia. In exchange, BioLineRx will receive a $10 million upfront payment and is eligible to receive up to an additional $87 million of potential commercial milestones, plus royalties ranging from 18% to 23% on net sales of APHEXDA.
Reese81012
Posted - 1 hour ago
$BLRX got out of this a long time ago was hoping for the best for longs smh 🤦🏾♂️
timnim
Posted - 1 hour ago
$BLRX I’ve lost more than 50k in this bet. I am out now.
Humperdink
Posted - 1 hour ago
$BLRX buying here...
Jabed206
Posted - 1 hour ago
$BLRX Dying company it seems
gargoyl
Posted - 1 hour ago
$BLRX so J Loveland opens an account today to share his riveting 🧐 news .. suspect ,
What’s bigger at play , that these guys are paid ..
TwongStocks
Posted - 1 hour ago
$BLRX Here is the amendment to the loan with Kreos. https://www.sec.gov/Archives/edgar/data/1498403/000117891324003792/exhibit_10-2.htm It appears that most of the money from their deal with Ayrmid is going to go towards loan repayment. They received $10m upfront from Ayrmid. As well as $9m from the equity agreement. $19m. BLRX must make a $10m partial loan prepayment. They must also make a $6.5m payment in lieu of the revenue based fee owed to Kreos. So $16.5m must be paid right off the bat. Which eats up most of the money from the Ayrmid deal. Starting Dec 1, BLRX must begin repaying the outstanding loan balance. Schedule B of the filing has the payment amounts. Initial loan balance is $13.8m. Final payment is Dec 1, 2027.
gargoyl
Posted - 1 hour ago
$BLRX a little ditty from a gold miner who was the first to say “don’t throw the baby out with the bath water” . He went on to adjust his sluice to let rocks out and collect the nuggets. The News on 3QT Earnings must be such that they want in lower now. Reverse think 🤔 what they portray. Average in , they are. Who you think picked up 5M shares today.
Not retail!! Long the 🦋
johnsoriaknows
Posted - 1 hour ago
$BLRX this is dead now. They have nothing to show except a tittle cash which will disappear with new clinical research. It's like starting from zero with a management incapable of growing shareholder value. Expect R/S after R/S and a bunch of raises going forward
Humperdink
Posted - 2 hours ago
$BLRX just remember, oversold levels are a great buying opportunity here. Average down as a bounce will slingshot back over $1.00